Back to search

Article

Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody Levels

2021-10-18

Abstract excerpt

Recent studies using data accrued from global SARS-CoV-2 vaccination efforts have demonstrated that breakthrough infections are correlated with levels of neutralizing antibodies. The decrease in neutralizing antibody titers of vaccinated individuals over time, combined with the emergence of more infectious variants of concern has resulted in waning vaccine efficacy against infection and a rise in breakthrough infe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f21f9c9e-fede-5fb2-9624-181f6aef5771
DOI
10.1101/2021.10.13.21264921
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody LevelsDOI 10.1101/2021.10.13.21264921
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccinesSemantic proximity
IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunitySemantic proximity
Neutralising antibodies predict protection from severe COVID-19Semantic proximity
Employment of a high-throughput functional assay to define the critical factors that influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2.Semantic proximity
Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD studySemantic proximity
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernSemantic proximity
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2Semantic proximity
A statistical immune correlates of protection model for predicting efficacy from neutralizing antibody titers to establish immunobridging of monoclonal antibodies for prevention of COVID-19Semantic proximity
Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological dataSemantic proximity
Validation of neutralizing antibody titers for estimating vaccine effectiveness for the Omicron SARS-CoV-2 variant, BA.1Semantic proximity
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity
Select a neighboring publication to make it the new centre.